FEN PHEN CLAIMS DEADLINE APPROACHING AUGUST 2002
A nationwide Class Action Settlement has been reached with manufacturer American Home Products that resolves the claims of former Pondimin and Redux patients suffering serious and fatal heart conditions, including primary pulmonary hypertension (PPH). On January 11, 2002, the Fen Phen settlement became final, entitling the estimated 6 to 7 million Americans that have taken Fen Phen eligible for compensation. Under the Settlement it allows former Redux and Pondimin patients to receive compensation if they have developed the deadly and serious conditions that have been linked to the once popular diet drugs. If you have used the diet drug Fen Phen, including Redux and Pondimin, you are eligible to file a claim by August 2002.

If you would like to learn more about your legal rights regarding the Redux/ Pondimin recall, please contact us.
Contact Us

Contact Us

This site was designed by Fen Phen Attorneys. We are an affiliated group of attorneys from Texas who take on fen phen lawsuits throughout the country.

Patients suffering from Primary Pulmonary Hypertension (PPH) caused by Fen-Phen are NOT involved in the Nationwide Class Action Settlement Agreement with American Home Products. PPH patients must file independent lawsuits to make legal claims.

To learn your legal rights, please contact us by filling out the form below and speak with a PPH Lawyer for lawsuit information! Thank you for visiting a FenPhen Attorney!

First Name *
Last Name *
I wish to be referred to as:
(Mike, Michael, etc.)
Email *
Daytime Phone
Evening Phone
Address
City   State   Zip
Confirm Email *
I prefer to be contacted by email first
Comments
Your confidentiality matters. No information, including phone numbers and email addresses will be exchanged, shared or sold to a third party. Submissions do not constitute an Attorney/Client privilege. We look forward to hearing from you and will be in contact shortly.

 


Redux and Pondimin Side Effects

  • Primary Pulmonary Hypertension (PPH) is a dangerous disease that causes an increased pulmonary artery pressure that has been found to occur in Fen Phen, Redux, and Pondimin users. A study published in the New England Journal of Medicine back in 1996 found a twenty-three-
    fold increase in the risk of developing PPH when using diet drug Fen Phen for more than three months.

  • Valvular Heart Disease has occurred in Redux and Pondimin users that cause the valves in the heart to allow blood to flow backward through them that can lead to regurgitation.

  • Endocardial Fibrosis is an uncommon Redux and Pondimin side effect that is diagnosed by fibrosis and restrictive cardiomyo-
    pathy.

Top of Page